Serengen

Serengen is a biotechnology company based in Dortmund, Germany, specializing in DNA-encoded library (DEL) technology for drug discovery. The company's proprietary platform enables the synthesis and screening of massive chemical libraries, facilitating the rapid identification of small molecule hits for diverse therapeutic targets. By combining combinatorial chemistry with DNA-tagging, Serengen provides a highly efficient approach to early-stage drug development for pharmaceutical and biotech partners. The company operates as a spin-off from the Technical University of Dortmund, focusing on expanding the chemical space accessible for drug discovery. Their technology is designed to significantly reduce the time and cost associated with traditional high-throughput screening methods.